FDA Inspection 1150163 — Sarah D. Atkinson, M.D.
The FDA completed an inspection of Sarah D. Atkinson, M.D. on July 20, 2021 in Rochester, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 20, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rochester, NY (United States)
Additional Details
Clinical Investigator (CI)